SavedAdd your journal

Journals / Cukurova Medical Journal / 2013 / Cilt: 38 - Sayı: 1

Progesterone Inhibits Human Myometrial Contractions by Action on Membrane Receptors

Progesteronun insan myometrium kontraksiyonlarını membran reseptörleri aktivasyonu ile inhibisyonu

Remzi GOKDENİZ
Ali OVAYOLU
Robert GARFİELD
Pages
—–2
Publication Date
2013-03-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusions: P4 rapidly inhibits myometrial contractility by nongenomic mechanisms through action on mPR but not via cAMP, cGMP, or NO

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background: The mechanisms for myometrial inhibition are still being investigated Aim: To examine mechanisms of progesterone (P4) inhibition of uterine contractility.
📊
Key Findings & Data:During 2010-2011, 24 women given birth by cesarean section.
💡
Conclusion & Impact:Conclusions: P4 rapidly inhibits myometrial contractility by nongenomic mechanisms through action on mPR but not via cAMP, cGMP, or NO
🔬Design:Research Article
📍Scope:2010-2011 Verileri
⚙️Variables:Siklik adenozin monofosfat · myometriyum · erken doğum

Abstract

Background: The mechanisms for myometrial inhibition are still being investigated Aim: To examine mechanisms of progesterone (P4) inhibition of uterine contractility. Methods: Prospective study Tertiary care center at St. Joseph"s Hospital and at Maricopa Hospital, Phoenix, AZ and research center in Arizona, USA. During 2010-2011, 24 women given birth by cesarean section. Uterine tissues from women (n=24) at term were suspended in organ chambers and exposed to various agents. Contractility was registered and compared before and after addition of agents. Tissues were treated with P4 alone, a progestin (R5020) with low affinity to the progesterone membrane receptor (mPR), or a non-sex steroid (cholesterol). Other tissues were pretreated with inhibitors of adenylate cyclase (SQ 22536), phosphodiesterase (rolipram), nitric oxide (NO) synthases (L-NAME) or a nuclear P4 receptor antagonist (mifepristone, MIF), followed by P4. Data were analyzed by ANOVA. Results: P4 (P0.05) inhibitory effects. P4 inhibition is not blocked by MIF, SQ, ODQ, rolipram or L-NAME (P>0.05). Conclusions: P4 rapidly inhibits myometrial contractility by nongenomic mechanisms through action on mPR but not via cAMP, cGMP, or NO

Özet

Geçmiş: Myometriyal inhibisyon mekanizmaları hala araştırılmaktadır. Amaç: Uterin kontraksiyonlar üzerine progesteron (P4) inhibisyon mekanizmalarını değerlendirmektir. Metot: Prospektif çalışma St. Joseph"s Hospital ve Maricopa Hospital, Phoenix, AZ and research center in Arizona, ABD\'deyapılmıştır. Çalışma 2010-2011 yılları arasında sezaryan ile doğum yapmış kadınlarda yapıldı. Termde 24 kadından toplanan uterin dokular çeşitli ajanlara maruz bırakıldı. Kontraktilite, ajanların öncesi ve sonrasında karşılaştırıldı ve kaydedildi. Dokular progesteron membran reseptörüne (mPR), düşük affinite gösteren sadece bir progestinle (R5020) veya non-seks stereoid (kolesterol) ile tedavi edildi. Diğer dokular ise adenilatsiklaz (SQ 22536), guanilatsiklaz (ODQ), fosfodiesteraz (rolipram), nitrikoksit (NO) sentaz (L-NAME) inhibitörleri veya bir nükleer P4 reseptörantagonisti (mifepristone, MIF) uygulandıktan sonra, P4 ile tedavi edildi. Veriler ANOVA ile analiz edildi. Sonuçlar: P4 uterin kontraksiyonları inhibe etti (P0.05). P4 inhibisyonu MIF, SQ, ODQ, rolipram veya L-NAME ile etkilenmemiştir (P>0.05). Tartışma :P4 cAMP, cGMPveya NO aracılığı ile değil; nongenomik mPR aktivasyonu ile myometrial kontraksiyonlari hızlıca inhibe etmektedir.

🔖

Cite This Article

GOKDENİZ, R., OVAYOLU, A., GARFİELD, R. (2013). Progesterone Inhibits Human Myometrial Contractions by Action on Membrane Receptors. Cukurova Medical Journal, Cilt: 38 - Sayı: 1. https://ajindex.com/articles/57180

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Fsapo A. Force of labour. In: Iffy L, Kaminetzky HA, editors. Principles and Practice of Obstetrics and Perinatology. John Wiley and Sons, Inc. 1981; 7617 Chwalisz K, Hegele-Hartung C, Schulz R, Shi SQ, Louton PT. Progesterone control of cervical ripening - experimental studies with the progesterone antagonists onapristone, lilopristone and mifepristone. In: Leppert P, Woessner F, editors. The Extracellular Matrix of the Uterus, Cervix and Fetal Membranes: Synthesis, Degradation and Hormonal Regulation. Perinatology Press. 1991; 119-131.
  2. Chwalisz K, Garfield RE. Regulation of the uterus and cervix during pregnancy and labor. Ann NY Acad Sci. 1997; 828: 238-53.
  3. Hegele-Hartung C, Chwalisz K, Beier HM, Elger W. Ripening of the uterine cervix of the guinea-pig after treatment with the progesterone antagonist Onapristone (Zk-98.299) - an electron-microscopic study. Hum Reprod. 1989; 4: 369-77.
  4. Johnson JW, Austin KL, Jones GS, Davis GH, and King TM. Efficacy of 17 alpha-hydroxyprogesterone caproate in the prevention of premature labor. N Engl J Med. 1975; 293: 675-80.
  5. Yemini M, Borenstein R, Dreazen E. Prevention of premature labor by 17 alpha-hydroxyprogesterone caproate in the prevention of premature labor. Am J Obstet Gynaecol. 1985; 151: 574-77.
  6. Harrikainen-Sorri AL, Kauppila, A, Tuimala, R. Inefficacy of 17 alpha-hydroxyprogesterone caproate in the prevention of prematurity in twin pregnancy. Obstet Gynaecol. 1980; 56: 692-95. Keirse MJ. Progestogen administration in pregnancy may prevent preterm delivery. Br J Obstet Gynaecol. 1990; 97: 149-54.
  7. Meis PJ, Klebanoff M, Thom E, Dombrowski MP, Sibai B, Moawad AH, et al. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Eng J Med. 2003; 348: 2379-85. da Fonseca EB, Bittar RE, Carvalho MHB, Zugaib M. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study. Am J Obstet Gynaecol. 2003; 188: 419-24.
  8. Barnafi L, Larraguibel R. The in vitro effect of progesterone and oestrogens on thespontaneous and oxytocin-induced activity of the human myometrium. Acta Endocrinol. 1974; 76: 172-7.
  9. Batra S, Bengtsson B. Effects of diethylstilboestrol and ovarian steroids on the contractile responses and calcium movements in rat uterine smooth muscle. J Physiol. 1978; 276: 329-42.
  10. Fu X, Rezapour M, Lofgren M, Ulmsten U, Backstrom T. Antianaphylactic effects of